Cogent Biosciences (COGT) Assets: 2017-2021
Historic Assets for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $215.4 million.
- Cogent Biosciences' Assets rose 53.99% to $215.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $215.4 million, marking a year-over-year increase of 53.99%. This contributed to the annual value of $250.9 million for FY2020, which is 407.69% up from last year.
- As of Q3 2021, Cogent Biosciences' Assets stood at $215.4 million, which was down 5.75% from $228.5 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Assets registered a high of $250.9 million during Q4 2020, and its lowest value of $31.1 million during Q2 2020.
- Moreover, its 3-year median value for Assets was $81.3 million (2019), whereas its average is $127.3 million.
- Its Assets has fluctuated over the past 5 years, first tumbled by 55.19% in 2020, then skyrocketed by 635.84% in 2021.
- Over the past 5 years, Cogent Biosciences' Assets (Quarterly) stood at $49.1 million in 2017, then spiked by 74.95% to $85.9 million in 2018, then tumbled by 42.48% to $49.4 million in 2019, then spiked by 407.69% to $250.9 million in 2020, then spiked by 53.99% to $215.4 million in 2021.
- Its Assets stands at $215.4 million for Q3 2021, versus $228.5 million for Q2 2021 and $237.6 million for Q1 2021.